The pathogenic role for Smad3 in T2D and T2DN comes from our recent studies that genetic deletion of Smad3 from db/db mice can protect against the development of T2D and T2DN as well as myocardial disease and diabetic dyslipidemia 20-23. This evidence concerns the gene SMAD3 and myocardial disorder.